# GLOW Research Guide: Identity, Literature, Analysis and Documentation

> Markdown copy of https://starbio.org/glow-research-guide/ for language models and reading tools. The web page is the reference version: cite that address. Page last updated November 12, 2026.
>
> Research use only. StarBio supplies materials for in vitro laboratory research. They are not for human or veterinary use.

*Research use only. StarBio products are supplied strictly for in-vitro laboratory research by qualified professionals. They are not for human or veterinary use, not for diagnostic or therapeutic use, and have not been evaluated by the FDA. This guide covers identity, documentation and handling only. It is not usage guidance.*

GLOW is StarBio’s name for a three-component blend: BPC-157, TB-500 and the copper tripeptide GHK-Cu, lyophilized together in one 70 mg vial. A blend is harder to document than a single peptide, because one purity figure has to describe three molecules of very different size, and one of them carries a metal. This page sets out what the components are, which research areas their separate literatures cover, what a certificate for a three-part blend should show, and the report on file for StarBio’s lot.

## Identity

| Name | GLOW (BPC-157, TB-500 and GHK-Cu blend) |
| --- | --- |
| Type | Multi-peptide research blend, three components in one lyophilized vial |
| Components | BPC-157 (1419.54 g/mol), TB-500 (889.02 g/mol), GHK-Cu (340.38 g/mol as free peptide) |
| Labelled total | 70 mg |

GLOW70 mg · $89.99For laboratory research use only.

[View product](https://starbio.org/product/glow/)

## Origin and history

There is no single discovery behind a blend. BPC-157 is a 15-residue sequence described in the early 1990s as a fragment of a protein found in gastric juice. TB-500 is the acetylated 17 to 23 fragment of thymosin beta-4, the actin-binding segment of a 43-residue protein. GHK is a tripeptide first described by Loren Pickart in 1973 in human plasma and studied since then mostly as its copper(II) complex. Each has its own research guide with full identity data. The combination itself is a catalogue product: there is no published literature on the three together, and this page does not claim any.

## What the literature covers

The references on file for this compound span several research areas. They are listed here as areas of study, not as results.

- **GHK and its copper complex.** A 2008 review of the tripeptide in tissue remodelling [1], fibroblast culture and wound-model work from 1995 [7], matrix metalloproteinase expression in wounds (1999) [10] and a 2025 hydrogel biomaterial study [4].
- **BPC-157.** A tendon cell study in the *Journal of Applied Physiology* (2011) [5], vascular signalling in rats (2020) [8], pharmacokinetics in rats and dogs (2022) [11] and a 2025 systematic review [2].
- **Thymosin beta-4.** Reviews of its basic properties (2012) [3], animal studies (2010) [6], ocular research (2018) [9] and a 2023 review [12].

Every reference concerns one of the individual molecules. Much of the thymosin beta-4 literature describes the full 43-residue protein, not the seven-residue fragment in this vial.

## Analytical notes

A three-component blend should show three resolved main peaks on a reverse-phase chromatogram. The components differ widely: GHK is a 340 Da tripeptide that elutes early, TB-500 is 889 Da, and BPC-157 at 1419.5 Da is the most retained. A single purity figure for a blend is the summed area of the expected peaks against everything else. It says the vial contains little besides the three components. It does not say how much of each is present, which is a separate measurement (quantification per component) and the more informative one for any blend.

Mass spectrometry should confirm all three masses. Two further points follow from the copper: the complex colours the powder and its solutions blue, and copper(II) can catalyse oxidation in solution, so a blend that contains GHK-Cu is best treated as less stable in solution than its copper-free components. None of the three peptides contains methionine, cysteine or tryptophan, so the usual oxidation sites are absent from the sequences themselves. The difference between area percent and content by weight is explained in [what 99% purity means](https://starbio.org/what-99-percent-purity-means/).

## Storage and stability

- Lyophilized powder
- Store at -20 °C
- Protect from light
- Avoid repeated freeze-thaw cycles
- In solution: 2-8 °C, short term

## Documentation for StarBio lots

Every StarBio lot is analysed by an independent laboratory. The table lists the report on file for this compound.

| Variant | Laboratory / report | HPLC purity | Labelled / measured | Tested |  |
| --- | --- | --- | --- | --- | --- |
| GLOW 70 mg | Medutest WWB-BBG70-2871 | 98.45% | 70 mg | Feb 14, 2026 | [report](https://starbio.org/wp-content/uploads/2026/07/coa-medutest-GLOW_GHK-CU_50mgTB500_10mgBPC157_10mg_70mg.webp) |

Current certificates are in the [COA Library](https://starbio.org/coa/); the [verify-lot form](https://starbio.org/verify-lot/) connects an order to its batch record.

## References

1. [The human tri-peptide GHK and tissue remodeling](https://pubmed.ncbi.nlm.nih.gov/18644225/). Journal of biomaterials science. Polymer edition, 2008, PMID 18644225.
2. [Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review](https://pubmed.ncbi.nlm.nih.gov/40756949/). HSS Journal (NIH/PubMed Central), 2025, PMID 40756949.
3. [Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications](https://pubmed.ncbi.nlm.nih.gov/22074294/). Expert opinion on biological therapy, 2012, PMID 22074294.
4. [Food-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing](https://pubmed.ncbi.nlm.nih.gov/39902373/). Biomaterials research, 2025, PMID 39902373.
5. [The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration](https://pubmed.ncbi.nlm.nih.gov/21030672/). Journal of Applied Physiology, 2011, PMID 21030672.
6. [Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide](https://pubmed.ncbi.nlm.nih.gov/20536453/). Annals of the New York Academy of Sciences, 2010, PMID 20536453.
7. [Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts](https://pubmed.ncbi.nlm.nih.gov/8836453/). Archives internationales de pharmacodynamie et de therapie, 1995, PMID 8836453.
8. [Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats](https://pubmed.ncbi.nlm.nih.gov/33046803/). Scientific Reports (Nature), 2020, PMID 33046803.
9. [Thymosin beta 4 and the eye: the journey from bench to bedside](https://pubmed.ncbi.nlm.nih.gov/30063853/). Expert opinion on biological therapy, 2018, PMID 30063853.
10. [Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+](https://pubmed.ncbi.nlm.nih.gov/10383745/). The Journal of investigative dermatology, 1999, PMID 10383745.
11. [Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1026182/full). Frontiers in Pharmacology, 2022.
12. [Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies](https://pubmed.ncbi.nlm.nih.gov/36709593/). International immunopharmacology, 2023, PMID 36709593.

Product page: [GLOW](https://starbio.org/product/glow/). Related guides: [BPC-157 research guide](https://starbio.org/bpc-157-research-guide/), [TB-500 research guide](https://starbio.org/tb-500-research-guide/), [GHK-Cu research guide](https://starbio.org/ghk-cu-research-guide/), [what 99% purity means](https://starbio.org/what-99-percent-purity-means/), [storing lyophilized peptides](https://starbio.org/storing-lyophilized-research-peptides/).

*For laboratory research use only. Not for human or veterinary use.*

## Questions about GLOW

### What is GLOW?

GLOW is a multi-peptide research blend. It is supplied for in vitro laboratory research only. This guide covers identity, documentation and handling, not use.

### Is GLOW the same as BPC-157 / TB-500 / GHK-Cu blend?

GLOW is also listed as BPC-157 / TB-500 / GHK-Cu blend. On a certificate or vial label, the sequence identify the material regardless of which name is used.

### Is StarBio's GLOW independently tested?

Yes. The current GLOW batch was tested by Medutest (Medutest report WWB-BBG70-2871): 98.45% purity by HPLC, tested Feb 14, 2026. The report is on file in the [COA library](https://starbio.org/coa/) ([report page](https://starbio.org/coa/glow-70-mg-medutest-wwb-bbg70-2871/)).

### How should GLOW be stored?

Lyophilized powder; Store at -20 °C; Protect from light; Avoid repeated freeze-thaw cycles; In solution: 2-8 °C, short term. StarBio ships it as sealed lyophilized powder.

### Where can I buy GLOW for laboratory research?

StarBio sells [GLOW](https://starbio.org/product/glow/) as 70 mg at $89.99, shipped tracked from Florida to all 50 US states. StarBio does not ship internationally. Buyers must be qualified researchers or institutions aged 21 or older, buying for in vitro laboratory work.

---

StarBio: https://starbio.org/ | Site summary for language models: https://starbio.org/llms.txt | Laboratory report data: https://starbio.org/coa.json
